CANCER AFTER EXPOSURE TO METRONIDAZOLE

被引:52
作者
BEARD, CM
NOLLER, KL
OFALLON, WM
KURLAND, LT
DAHLIN, DC
机构
[1] MAYO CLIN & MAYO FDN, DEPT OBSTET & GYNECOL, ROCHESTER, MN 55905 USA
[2] MAYO CLIN & MAYO FDN, BIOSTAT SECT, ROCHESTER, MN 55905 USA
[3] MAYO CLIN & MAYO FDN, SURG PATHOL SECT, ROCHESTER, MN 55905 USA
关键词
D O I
10.1016/S0025-6196(12)64947-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:147 / 153
页数:7
相关论文
共 43 条
  • [31] METRONIDAZOLE - REVIEW OF USES AND TOXICITY
    ROE, FJC
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1977, 3 (03) : 205 - 212
  • [32] ROE FJC, 1983, SURGERY, V93, P158
  • [33] METRONIDAZOLE
    ROSENBLATT, JE
    EDSON, RS
    [J]. MAYO CLINIC PROCEEDINGS, 1987, 62 (11) : 1013 - 1017
  • [34] MUTAGENICITY OF METRONIDAZOLE - ACTIVATION BY MAMMALIAN LIVER-MICROSOMES
    ROSENKRANZ, HS
    SPECK, WT
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1975, 66 (02) : 520 - 525
  • [35] RUSTIA M, 1972, JNCI-J NATL CANCER I, V48, P721
  • [36] Shimizu H, 1982, Natl Cancer Inst Monogr, V62, P161
  • [37] INCREASED INCIDENCE OF EXPERIMENTAL COLON CANCER ASSOCIATED WITH LONG-TERM METRONIDAZOLE THERAPY
    SLOAN, DA
    FLEISZER, DM
    RICHARDS, GK
    MURRAY, D
    BROWN, RA
    [J]. AMERICAN JOURNAL OF SURGERY, 1983, 145 (01) : 66 - 70
  • [38] VINCENT RG, 1977, CANCER, V39, P1647, DOI 10.1002/1097-0142(197704)39:4<1647::AID-CNCR2820390439>3.0.CO
  • [39] 2-H
  • [40] 1986, MINNESOTA HLTH STATI, P77